11.50Open15.30Pre Close1 Volume3 Open Interest420.00Strike Price1.15KTurnover30.67%IV0.88%PremiumJan 10, 2025Expiry Date7.89Intrinsic Value100Multiplier1DDays to Expiry3.61Extrinsic Value100Contract SizeAmericanOptions Type-0.8310Delta0.0317Gamma48.20Leverage Ratio-0.5950Theta-0.0120Rho-40.05Eff Leverage0.0660Vega
Vertex Pharmaceuticals Stock Discussion
nfa
SiteOne’s efforts in non-opioid pain management put it in a unique position relative to Vertex Pharmaceuticals, a major player in the field known for its successful development of cystic fibrosis treatments. Vertex has also been working on non-opioid pain drugs, specifically targeting the NaV1.8 sodium channel, a focal point shared by SiteOne’s lead pro...
At 4:02 p.m. ET, the three indices closed lower. The $Dow Jones Industrial Average (.DJI.US)$ was off 0.70%, losing 300 points. The $S&P 500 Index (.SPX.US)$ was down 1.32% and the $Nasdaq Composite Index (.IXIC.US)$ was off 2.24%.
MACRO
In macro, core retail sales grew by 0.1% month over month, lower than estimated. ...
My name is Kevin Travers and the market is falling today- here is why.
$Alibaba (BABA.US)$ shares declined after a report from the firm Friday morning that it was facing a consumer demand slump, even though its AI cloud business grew 7% to $4.2B in its second fiscal quarter.
$Applied Materials (AMAT.US)$ fell 8% after r...
📊⚡️📊
yahoo.com/news/...
No comment yet